Page last updated: 2024-08-26

phenylacetylglutamine and Chronic Disease

phenylacetylglutamine has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fan, Q; Pan, R; Tao, R; Yang, Q; Zhuang, L; Zong, X1

Other Studies

1 other study(ies) available for phenylacetylglutamine and Chronic Disease

ArticleYear
Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure.
    ESC heart failure, 2022, Volume: 9, Issue:4

    Topics: Chronic Disease; Glutamine; Heart Failure; Humans; Kidney Diseases; Prognosis; Risk Factors

2022